유방확대수술 시장 규모, 점유율 및 동향 분석 보고서 : 시술 방법별, 표면별, 형상별, 용도별, 최종 용도별, 지역별 및 부문별 예측(2026-2033년)

Breast Augmentation Market Summary

The global breast augmentation market size was valued at USD 2.0 billion in 2025 and is projected to grow from USD 2.1 billion in 2026 to USD 3.0 billion by 2033, growing at a CAGR of 5.3% from 2026 to 2033. The growth of the global breast augmentation market is driven by the increasing focus on physical appearance and growing acceptance of cosmetic procedures.

Consumers are more conscious about body image, influenced by social media, celebrity culture, and changing beauty standards. This has encouraged a larger population, particularly in urban areas, to opt for breast augmentation procedures to enhance confidence and self-esteem. Breast augmentation, also known as augmentation mammoplasty, is a surgical procedure performed to increase the size and improve the shape of the breasts. This is typically achieved by placing breast implants either under the breast tissue or beneath the chest muscles. The procedure is widely chosen for both cosmetic and reconstructive purposes, depending on individual needs and medical conditions. In addition, the rising volume of cosmetic surgery procedures are being performed worldwide.

This growth is largely attributed to increasing awareness about aesthetic treatments and the growing desire among individuals to enhance their physical appearance. Breast augmentation remains one of the most performed cosmetic procedures due to its ability to improve body proportion, restore breast volume after weight loss or pregnancy, and enhance overall confidence. For instance, according to the American Society of Plastic Surgeons (ASPS) Procedural Statistics Report, the number of breast augmentation procedures has shown a consistent upward trend over recent year. The total procedures increased from 298,568 in 2022 to 304,181 in 2023 and further reached 306,196 in 2024. This steady rise highlights the growing demand for breast augmentation as one of the most preferred cosmetic surgical procedures. The increasing procedure volume reflects higher consumer acceptance, improved awareness, and advancements in surgical safety and outcomes. It also indicates that more individuals are opting for aesthetic enhancements to improve body image and confidence. Such consistent growth in procedure numbers reinforces the strong contribution of cosmetic surgery trends toward the expansion of the breast augmentation market.

Global Breast Augmentation Market Report Segmentation

This report forecasts revenue growth at global, regional & country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global breast augmentation market report based on procedure type, surface, shape, application, end use, and region:

• Procedure Type Outlook (Revenue, USD Million, 2021 - 2033)
• Breast Implants
• By Product
  • Silicone
  • Saline
• By Incision Procedure
  • Periareolar
  • Inframammary
  • Transaxillary
• Fat Transfer
• Surface Outlook (Revenue, USD Million, 2021 - 2033)
• Smooth
• Textured
• Shape Outlook (Revenue, USD Million, 2021 - 2033)
• Round
• Anatomical
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Cosmetic Surgery
• Reconstructive Surgery
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals
• Cosmetology Clinics
• Ambulatory Surgical Centers
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Thailand
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
  • 1.1.1. Procedure Type
  • 1.1.2. Surface
  • 1.1.3. Shape
  • 1.1.4. Application
  • 1.1.5. End Use
  • 1.1.6. Regional scope
  • 1.1.7. Estimates and forecast timeline
• 1.2. Market Definitions
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
• 1.5. Details of primary research
  • 1.5.1. Data for primary interviews in North America
  • 1.5.2. Data for primary interviews in Europe
  • 1.5.3. Data for primary interviews in Asia Pacific
  • 1.5.4. Data for primary interviews in Latin America
  • 1.5.5. Data for Primary interviews in MEA
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.1.1. Approach 1: Commodity flow approach
  • 1.7.2. Volume price analysis (Model 2)
    • 1.7.2.1. Approach 2: Volume price analysis
• 1.8. Research Scope and Assumptions
  • 1.8.1. List of Secondary Sources
  • 1.8.2. List of Primary Sources
  • 1.8.3. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Breast Augmentation Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Drivers Analysis
    • 3.2.1.1. Rising demand for aesthetic and cosmetic procedures globally
    • 3.2.1.2. Technological advancements in implant materials and surgical techniques
    • 3.2.1.3. Growing medical tourism in countries offering cost-effective procedures
    • 3.2.1.4. Increasing disposable income in emerging economies
    • 3.2.1.5. Strong influence of social media and celebrity culture
  • 3.2.2. Market Restraints Analysis
    • 3.2.2.1. Risk of surgical complications and side effects
    • 3.2.2.2. Limited reimbursement or insurance coverage
  • 3.2.3. Market Opportunity Analysis
    • 3.2.3.1. Growing demand for natural-looking and customized results
    • 3.2.3.2. Expansion in emerging markets (Asia-Pacific)
    • 3.2.3.3. Integration of AI and 3D imaging for surgical planning
    • 3.2.3.4. Expansion of outpatient and ambulatory surgical centers
  • 3.2.4. Market Challenge Analysis
    • 3.2.4.1. Managing patient expectations regarding outcomes
    • 3.2.4.2. Price sensitivity in developing regions
• 3.3. Breast Augmentation Market Analysis Tools
  • 3.3.1. Porter's Analysis
    • 3.3.1.1. Bargaining power of the suppliers
    • 3.3.1.2. Bargaining power of the buyers
    • 3.3.1.3. Threats of substitution
    • 3.3.1.4. Threats from new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic and Social landscape
    • 3.3.2.3. Technological landscape
    • 3.3.2.4. Environmental landscape
    • 3.3.2.5. Legal landscape

Chapter 4. Breast Augmentation Market: Procedure Type Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Breast Augmentation Market: Procedure Type Movement Analysis, 2025 & 2033 (USD Million)
• 4.3. Global Breast Augmentation Market Size & Trend Analysis, by Procedure Type 2021 to 2033 (USD Million)
• 4.4. Breast Implants
  • 4.4.1. Breast implants market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.4.2. By Product
    • 4.4.2.1. By Product market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.2.2. Silicone
      • 4.4.2.2.1. Silicone market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.2.3. Saline
      • 4.4.2.3.1. Saline market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.4.3. By Incision Procedure
    • 4.4.3.1. By incision procedure market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.3.2. Periareolar
      • 4.4.3.2.1. Periareolar market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.3.3. Inframammary
      • 4.4.3.3.1. Inframammary market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.3.4. Transaxillary
      • 4.4.3.4.1. Transaxillary market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• 4.5. Fat Transfer
  • 4.5.1. Fat transfer market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. Breast Augmentation Market: Surface Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Breast Augmentation Market: Surface Movement Analysis, 2025 & 2033 (USD Million)
• 5.3. Global Breast Augmentation Market Size & Trend Analysis, by Surface 2021 to 2033 (USD Million)
• 5.4. Smooth
  • 5.4.1. Smooth market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• 5.5. Textured
  • 5.5.1. Textured market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. Breast Augmentation Market: Shape Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global Breast Augmentation Market: Shape Movement Analysis, 2025 & 2033 (USD Million)
• 6.3. Global Breast Augmentation Market Size & Trend Analysis, by Shape 2021 to 2033 (USD Million)
• 6.4. Round
  • 6.4.1. Round market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• 6.5. Anatomical
  • 6.5.1. Anatomical market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 7. Breast Augmentation Market: Application Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Global Breast Augmentation Market: Application Movement Analysis, 2025 & 2033 (USD Million)
• 7.3. Global Breast Augmentation Market Size & Trend Analysis, by Application 2021 to 2033 (USD Million)
• 7.4. Cosmetic Surgery
  • 7.4.1. Cosmetic surgery market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• 7.5. Reconstructive Surgery
  • 7.5.1. Reconstructive surgery market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 8. Breast Augmentation Market: End Use Estimates & Trend Analysis

• 8.1. Segment Dashboard
• 8.2. Global Breast Augmentation Market: End Use Movement Analysis, 2025 & 2033 (USD Million)
• 8.3. Global Breast Augmentation Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
• 8.4. Hospitals
  • 8.4.1. Hospitals market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• 8.5. Cosmetology Clinics
  • 8.5.1. Cosmetology clinics market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• 8.6. Ambulatory Surgical Centers
  • 8.6.1. Ambulatory surgical centers market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 9. Breast Augmentation Market: Regional Estimates & Trend Analysis by Procedure Type, Surface, Shape, Application, And End Use

• 9.1. Regional Dashboard
• 9.2. Market Size and Trend Analysis, 2021 to 2033
• 9.3. North America
  • 9.3.1. North America breast augmentation market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.3.2. U.S.
    • 9.3.2.1. Key country dynamics
    • 9.3.2.2. Competitive scenario
    • 9.3.2.3. Regulatory framework
    • 9.3.2.4. Reimbursement scenario
    • 9.3.2.5. U.S. breast augmentation market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.3.3. Canada
    • 9.3.3.1. Key country dynamics
    • 9.3.3.2. Competitive scenario
    • 9.3.3.3. Regulatory framework
    • 9.3.3.4. Reimbursement scenario
    • 9.3.3.5. Canada breast augmentation market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.3.4. Mexico
    • 9.3.4.1. Key country dynamics
    • 9.3.4.2. Competitive scenario
    • 9.3.4.3. Regulatory framework
    • 9.3.4.4. Reimbursement scenario
    • 9.3.4.5. Mexico breast augmentation market estimates and forecasts, 2021 - 2033 (USD Million)
• 9.4. Europe
  • 9.4.1. Europe breast augmentation market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.4.2. UK
    • 9.4.2.1. Key country dynamics
    • 9.4.2.2. Competitive scenario
    • 9.4.2.3. Regulatory framework
    • 9.4.2.4. Reimbursement scenario
    • 9.4.2.5. UK breast augmentation market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.4.3. Germany
    • 9.4.3.1. Key country dynamics
    • 9.4.3.2. Competitive scenario
    • 9.4.3.3. Regulatory framework
    • 9.4.3.4. Reimbursement scenario
    • 9.4.3.5. Germany breast augmentation market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.4.4. France
    • 9.4.4.1. Key country dynamics
    • 9.4.4.2. Competitive scenario
    • 9.4.4.3. Regulatory framework
    • 9.4.4.4. Reimbursement scenario
    • 9.4.4.5. France breast augmentation market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.4.5. Italy
    • 9.4.5.1. Key country dynamics
    • 9.4.5.2. Competitive scenario
    • 9.4.5.3. Regulatory framework
    • 9.4.5.4. Reimbursement scenario
    • 9.4.5.5. Italy breast augmentation market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.4.6. Spain
    • 9.4.6.1. Key country dynamics
    • 9.4.6.2. Competitive scenario
    • 9.4.6.3. Regulatory framework
    • 9.4.6.4. Reimbursement scenario
    • 9.4.6.5. Spain breast augmentation market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.4.7. Sweden
    • 9.4.7.1. Key country dynamics
    • 9.4.7.2. Competitive scenario
    • 9.4.7.3. Regulatory framework
    • 9.4.7.4. Reimbursement scenario
    • 9.4.7.5. Sweden breast augmentation market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.4.8. Denmark
    • 9.4.8.1. Key country dynamics
    • 9.4.8.2. Competitive scenario
    • 9.4.8.3. Regulatory framework
    • 9.4.8.4. Reimbursement scenario
    • 9.4.8.5. Denmark breast augmentation market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.4.9. Norway
    • 9.4.9.1. Key country dynamics
    • 9.4.9.2. Competitive scenario
    • 9.4.9.3. Regulatory framework
    • 9.4.9.4. Reimbursement scenario
    • 9.4.9.5. Norway breast augmentation market estimates and forecasts, 2021 - 2033 (USD Million)
• 9.5. Asia Pacific
  • 9.5.1. Asia Pacific breast augmentation market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.5.2. China
    • 9.5.2.1. Key country dynamics
    • 9.5.2.2. Competitive scenario
    • 9.5.2.3. Regulatory framework
    • 9.5.2.4. Reimbursement scenario
    • 9.5.2.5. China breast augmentation market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.5.3. Japan
    • 9.5.3.1. Key country dynamics
    • 9.5.3.2. Competitive scenario
    • 9.5.3.3. Regulatory framework
    • 9.5.3.4. Reimbursement scenario
    • 9.5.3.5. Japan breast augmentation market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.5.4. India
    • 9.5.4.1. Key country dynamics
    • 9.5.4.2. Competitive scenario
    • 9.5.4.3. Regulatory framework
    • 9.5.4.4. Reimbursement scenario
    • 9.5.4.5. India breast augmentation market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.5.5. South Korea
    • 9.5.5.1. Key country dynamics
    • 9.5.5.2. Competitive scenario
    • 9.5.5.3. Regulatory framework
    • 9.5.5.4. Reimbursement scenario
    • 9.5.5.5. South Korea breast augmentation market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.5.6. Australia
    • 9.5.6.1. Key country dynamics
    • 9.5.6.2. Competitive scenario
    • 9.5.6.3. Regulatory framework
    • 9.5.6.4. Reimbursement scenario
    • 9.5.6.5. Australia breast augmentation market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.5.7. Thailand
    • 9.5.7.1. Key country dynamics
    • 9.5.7.2. Competitive scenario
    • 9.5.7.3. Regulatory framework
    • 9.5.7.4. Reimbursement scenario
    • 9.5.7.5. Thailand breast augmentation market estimates and forecasts, 2021 - 2033 (USD Million)
• 9.6. Latin America
  • 9.6.1. Latin America breast augmentation market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.6.2. Brazil
    • 9.6.2.1. Key country dynamics
    • 9.6.2.2. Competitive scenario
    • 9.6.2.3. Regulatory framework
    • 9.6.2.4. Reimbursement scenario
    • 9.6.2.5. Brazil breast augmentation market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.6.3. Argentina
    • 9.6.3.1. Key country dynamics
    • 9.6.3.2. Competitive scenario
    • 9.6.3.3. Regulatory framework
    • 9.6.3.4. Reimbursement scenario
    • 9.6.3.5. Argentina breast augmentation market estimates and forecasts, 2021 - 2033 (USD Million)
• 9.7. Middle East and Africa
  • 9.7.1. Middle East and Africa breast augmentation market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.7.2. South Africa
    • 9.7.2.1. Key country dynamics
    • 9.7.2.2. Competitive scenario
    • 9.7.2.3. Regulatory framework
    • 9.7.2.4. Reimbursement scenario
    • 9.7.2.5. South Africa breast augmentation market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.7.3. Saudi Arabia
    • 9.7.3.1. Key country dynamics
    • 9.7.3.2. Competitive scenario
    • 9.7.3.3. Regulatory framework
    • 9.7.3.4. Reimbursement scenario
    • 9.7.3.5. Saudi Arabia breast augmentation market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.7.4. UAE
    • 9.7.4.1. Key country dynamics
    • 9.7.4.2. Competitive scenario
    • 9.7.4.3. Regulatory framework
    • 9.7.4.4. Reimbursement scenario
    • 9.7.4.5. UAE breast augmentation market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.7.5. Kuwait
    • 9.7.5.1. Key country dynamics
    • 9.7.5.2. Competitive scenario
    • 9.7.5.3. Regulatory framework
    • 9.7.5.4. Reimbursement scenario
    • 9.7.5.5. Kuwait breast augmentation market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 10. Competitive Landscape

• 10.1. Recent Developments & Impact Analysis by Key Market Participants
• 10.2. Company Categorization
• 10.3. Company Market Share Analysis, 2025
• 10.4. Company Heat Map Analysis
• 10.5. Strategy Mapping
  • 10.5.1. Expansion
  • 10.5.2. Mergers & Acquisition
  • 10.5.3. Partnerships & Collaborations
  • 10.5.4. New Technology Launches
  • 10.5.5. Research And Development
  • 10.5.6. Company Profiles
  • 10.5.7. ALLERGAN (AbbVie Inc.)
    • 10.5.7.1. Company overview
    • 10.5.7.2. Financial performance
    • 10.5.7.3. Product Benchmarking
    • 10.5.7.4. Strategic initiatives
  • 10.5.8. Johnson & Johnson
    • 10.5.8.1. Company overview
    • 10.5.8.2. Financial performance
    • 10.5.8.3. Product Benchmarking
    • 10.5.8.4. Strategic initiatives
  • 10.5.9. Sientra, Inc. (Tiger Aesthetics Medical, LLC)
    • 10.5.9.1. Company overview
    • 10.5.9.2. Financial performance
    • 10.5.9.3. Product Benchmarking
    • 10.5.9.4. Strategic initiatives
  • 10.5.10. SEBBIN
    • 10.5.10.1. Company overview
    • 10.5.10.2. Financial performance
    • 10.5.10.3. Product Benchmarking
    • 10.5.10.4. Strategic initiatives
  • 10.5.11. Establishment Labs
    • 10.5.11.1. Company overview
    • 10.5.11.2. Financial performance
    • 10.5.11.3. Product Benchmarking
    • 10.5.11.4. Strategic initiatives
  • 10.5.12. POLYTECH Health & Aesthetics GmbH
    • 10.5.12.1. Company overview
    • 10.5.12.2. Financial performance
    • 10.5.12.3. Product Benchmarking
    • 10.5.12.4. Strategic initiatives
  • 10.5.13. GC Aesthetics
    • 10.5.13.1. Company overview
    • 10.5.13.2. Financial performance
    • 10.5.13.3. Product Benchmarking
    • 10.5.13.4. Strategic initiatives
  • 10.5.14. HansBioMed
    • 10.5.14.1. Company overview
    • 10.5.14.2. Financial performance
    • 10.5.14.3. Product Benchmarking
    • 10.5.14.4. Strategic initiatives
  • 10.5.15. Bimini Health Tech
    • 10.5.15.1. Company overview
    • 10.5.15.2. Financial performance
    • 10.5.15.3. Product Benchmarking
    • 10.5.15.4. Strategic initiatives
  • 10.5.16. ARION LABORATORIES
    • 10.5.16.1. Company overview
    • 10.5.16.2. Financial performance
    • 10.5.16.3. Product Benchmarking
    • 10.5.16.4. Strategic initiatives
  • 10.5.17. SILIMED INDUSTRIA DE IMPANTES LTDA
    • 10.5.17.1. Company overview
    • 10.5.17.2. Financial performance
    • 10.5.17.3. Product Benchmarking
    • 10.5.17.4. Strategic initiatives
  • 10.5.18. Guangzhou Wanhe Plastic Material Co., Ltd
    • 10.5.18.1. Company overview
    • 10.5.18.2. Financial performance
    • 10.5.18.3. Product Benchmarking
    • 10.5.18.4. Strategic initiatives